A science journalist is writing about a study where a new AI-powered drug discovery platform reduced candidate molecule screening time from 7 months to 45 days. What is the percent decrease in screening time, expressed precisely?

Sat, 02 May 2026 21:26:28 +0000

**Why 7 Months Became a Milestone — And a New AI Platform Is Reshaping Drug Discovery** In a rapidly evolving landscape where speed and precision define progress, the drug discovery process has long been one of the slowest, most complex bottlenecks in medical innovation. For decades, identifying viable candidate molecules could take over seven months—a timeline that delays treatment access, drains research resources, and heightens patient uncertainty. Recent breakthroughs, however, are shifting these norms. A newly developed AI-powered platform has demonstrated a staggering reduction in candidate molecule screening time: from 210 days to just 45 days—marking not just a timeline shift, but a fundamental transformation in pharmaceutical development. This transformation is gaining real traction. As pharmaceutical costs mount and demands for faster treatments climb, innovations that shrink development timelines are attracting growing attention across research circles and health policy discussions. In the U.S. and beyond, stakeholders increasingly seek clarity on how such technology delivers tangible results—without overselling or overshadowing challenges. This is where precise, transparent data matters. **What Is the Actual Percent Reduction in Screening Time?**